RECRUITINGINTERVENTIONAL

FreeDom: Innovative Strategy for the Management of COPD Exacerbations

FreeDom : Innovative Strategy for the Management of COPD Exacerbations Combining Early Hospitalisation Discharge, Automated Oxygen Weaning at Home, Telemedicine and Tele-rehabilitation

About This Trial

The main objective of the study is to assess the "FreeDom" innovative strategy (FreeO2 at Domicile) to reduce hospitalization duration in patients with COPD exacerbation. This strategy associates early hospital discharge, automated O2 flow weaning with FreeO2 system, telemedicine and tele-rehabilitation. The main hypothesis of this study is that the FreeDom strategy will reduce the number of hospitalization day by 50 percent at day 30.

Who May Be Eligible (Plain English)

Who May Qualify: All patients hospitalized for COPD exacerbation for less than 48 hours will be considered. - known or suspected COPD to entry - Age \> or = 40 years - Ex-smoker history (10 pack / year or more) - Acute Exacerbation: dyspnea of recent onset (less than 15 days) - The need for oxygen therapy with a moderate rate: \<6L / min to maintain SpO2 \> 90% (for oxygen dependent patient, the oxygen flow must be higher than flow at home) Who Should NOT Join This Trial: - Refusal to consent to participate in the study, - Indication for an imminent intubation according to the pulmonologist, - Sleep Apnea - NIV used at home - Lack of FreeO2 system available at the time of randomization - Non-autonomous and alone at home - Patient alone at home - Patients who live more than 50 km from the hospital - Patient already included in the study within 3 months Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language

Inclusion Criteria: All patients hospitalized for COPD exacerbation for less than 48 hours will be considered. * known or suspected COPD to entry * Age \> or = 40 years * Ex-smoker history (10 pack / year or more) * Acute Exacerbation: dyspnea of recent onset (less than 15 days) * The need for oxygen therapy with a moderate rate: \<6L / min to maintain SpO2 \> 90% (for oxygen dependent patient, the oxygen flow must be higher than flow at home) Exclusion Criteria: * Refusal to consent to participate in the study, * Indication for an imminent intubation according to the pulmonologist, * Sleep Apnea * NIV used at home * Lack of FreeO2 system available at the time of randomization * Non-autonomous and alone at home * Patient alone at home * Patients who live more than 50 km from the hospital * Patient already included in the study within 3 months

Treatments Being Tested

OTHER

Control

The hospitalization will take place in the usual setting and the hospital discharge will be decided by pulmonologists according to the usual criteria

DEVICE

FreeDom

Early return home, patients using an innovative device that automatically adjusts and wean the oxygen flow (FreeO2 system) coupled to telemedicine and tele-rehabilitation

Locations (1)

Institut Universitaire de Cardiologie et de Pneumologie de Québec

Québec, Canada